Company Filing History:
Years Active: 2009-2013
Title: Masanori Inagaki: Innovator in Hyperglycemia Treatment
Introduction
Masanori Inagaki is a notable inventor based in Fukuoka, Japan. He has made significant contributions to the field of hyperglycemia treatment, holding a total of 5 patents. His work focuses on developing compounds that improve blood sugar levels and overall health.
Latest Patents
Inagaki's latest patents include innovative compounds such as a glycoside featuring a 4-methylergost-7-en-3-ol skeleton. This compound is utilized in a hyperglycemia improving agent, specifically a composition containing 0.001% by mass or more of the aforementioned compound. This extract is derived from a plant of the family Liliaceae, which serves as an active ingredient in the treatment of hyperglycemia. Another significant patent involves a drug designed to improve hyperglycemia, which includes compounds like 4-methylcholest-7-en-3-ol, 4-methylergost-7-en-3-ol, and 4-methylstigmast-7-en-3-ol. These compounds are recognized for their hyperglycemia improving effects and their ability to lower hemoglobin A1c levels.
Career Highlights
Masanori Inagaki is currently associated with Morinaga Milk Industry Co., Ltd., where he continues to innovate in the field of health and nutrition. His research and development efforts have led to advancements that benefit individuals dealing with hyperglycemia.
Collaborations
Inagaki has collaborated with esteemed colleagues such as Ryuuichi Higuchi and Hirotoshi Hayasawa. Their combined expertise has contributed to the successful development of new treatments and compounds.
Conclusion
Masanori Inagaki's work in the field of hyperglycemia treatment showcases his dedication to improving health outcomes through innovative solutions. His patents reflect a commitment to advancing medical science and providing effective treatments for those in need.